Bausch Health Companies Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bausch Health Companies Inc with three other pharmaceutical manufacturers in North America: Daiichi Sankyo Company Limited of UNITED STATES (2019 sales of $8.38 billion of which 93% was Prescription drugs), CSL Limited of UNITED STATES ($8.54 billion of which 84% was CSL Behring), and Regeneron Pharmaceuticals Incorporated which is also based in UNITED STATES ($7.86 billion of which 59% was EYLEA).

Sales Analysis. During the year ended December of 2019, sales at Bausch Health Companies Inc were C$11.38 billion (US$8.93 billion). This is an increase of 4.5% versus 2018, when the company's sales were C$10.89 billion. Sales of Salix saw an increase that was more than double the company's growth rate: sales were up 17.7% in 2019, from C$2.27 billion to C$2.68 billion. Not all segments of Bausch Health Companies Inc experienced an increase in sales in 2019: sales of Ortho Dermatologics fell 8.0% to C$747.60 million. Bausch Health Companies Inc also experienced decreases in sales in U.S. Diversified Products Segment (down 3.3% to C$1.69 billion) .